We further assessed siRNA-mediated PCTAIRE1-knockdown in other cell lines, and found that in breast cancer MDA-MB-468 cells PCTAIRE1-knockdown was effective at restoring sensitivity to Fas or TRAIL (S3A-F Fig). Here, CDK16 is linked to breast cancer.